National Research Corp Stock Fundamentals
| NRC Stock | USD 14.86 0.51 3.32% |
National Research Corp fundamentals help investors to digest information that contributes to National Research's financial success or failures. It also enables traders to predict the movement of National Stock. The fundamental analysis module provides a way to measure National Research's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to National Research stock.
At present, National Research's Interest Expense is projected to increase significantly based on the last few years of reporting. The current year's Total Revenue is expected to grow to about 179.4 M, whereas Total Other Income Expense Net is forecasted to decline to (78.4 K). National | Select Account or Indicator |
National Research Corp Company Return On Equity Analysis
National Research's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current National Research Return On Equity | 0.62 |
Most of National Research's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, National Research Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
National Return On Equity Historical Pattern
Today, most investors in National Research Stock are looking for potential investment opportunities by analyzing not only static indicators but also various National Research's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's return on equity growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of National Research return on equity as a starting point in their analysis.
National Research Return On Equity |
| Timeline |
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
National Total Stockholder Equity
Total Stockholder Equity |
|
Based on the latest financial disclosure, National Research Corp has a Return On Equity of 0.6177. This is 102.58% lower than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The return on equity for all United States stocks is notably lower than that of the firm.
National Research Corp Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining National Research's current stock value. Our valuation model uses many indicators to compare National Research value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across National Research competition to find correlations between indicators driving National Research's intrinsic value. More Info.National Research Corp is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers reporting about 0.28 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for National Research Corp is roughly 3.58 . At present, National Research's Return On Equity is projected to increase slightly based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the National Research's earnings, one of the primary drivers of an investment's value.National Research's Earnings Breakdown by Geography
National Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses National Research's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of National Research could also be used in its relative valuation, which is a method of valuing National Research by comparing valuation metrics of similar companies.National Research is currently under evaluation in return on equity category among its peers.
National Research ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, National Research's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to National Research's managers, analysts, and investors.Environmental | Governance | Social |
National Fundamentals
| Return On Equity | 0.62 | ||||
| Return On Asset | 0.17 | ||||
| Profit Margin | 0.17 % | ||||
| Operating Margin | 0.26 % | ||||
| Current Valuation | 413.7 M | ||||
| Shares Outstanding | 23.08 M | ||||
| Shares Owned By Insiders | 38.00 % | ||||
| Shares Owned By Institutions | 52.32 % | ||||
| Number Of Shares Shorted | 280.91 K | ||||
| Price To Earning | 26.72 X | ||||
| Price To Book | 11.36 X | ||||
| Price To Sales | 2.40 X | ||||
| Revenue | 148.58 M | ||||
| Gross Profit | 86.13 M | ||||
| EBITDA | 45.98 M | ||||
| Net Income | 30.97 M | ||||
| Cash And Equivalents | 32.97 M | ||||
| Cash Per Share | 1.33 X | ||||
| Total Debt | 38.96 M | ||||
| Debt To Equity | 0.37 % | ||||
| Current Ratio | 1.31 X | ||||
| Book Value Per Share | 1.35 X | ||||
| Cash Flow From Operations | 38.11 M | ||||
| Short Ratio | 3.77 X | ||||
| Earnings Per Share | 1.04 X | ||||
| Price To Earnings To Growth | 3.42 X | ||||
| Beta | 0.55 | ||||
| Market Capitalization | 343.01 M | ||||
| Total Asset | 122.44 M | ||||
| Retained Earnings | (30.53 M) | ||||
| Working Capital | (11.84 M) | ||||
| Current Asset | 27.6 M | ||||
| Current Liabilities | 12.83 M | ||||
| Annual Yield | 0.03 % | ||||
| Five Year Return | 1.24 % | ||||
| Net Asset | 122.44 M | ||||
| Last Dividend Paid | 0.48 |
About National Research Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze National Research Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of National Research using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of National Research Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 17.1 M | 14.4 M | |
| Total Revenue | 170.9 M | 179.4 M | |
| Cost Of Revenue | 64.4 M | 67.6 M | |
| Stock Based Compensation To Revenue | 0.01 | 0.01 | |
| Sales General And Administrative To Revenue | 0.24 | 0.21 | |
| Capex To Revenue | 0.12 | 0.08 | |
| Revenue Per Share | 5.45 | 3.88 | |
| Ebit Per Revenue | 0.24 | 0.21 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether National Research Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of National Research's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of National Research Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on National Research Corp Stock:Check out National Research Piotroski F Score and National Research Altman Z Score analysis. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of National Research. If investors know National will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about National Research listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.22) | Dividend Share 0.48 | Earnings Share 1.04 | Revenue Per Share | Quarterly Revenue Growth (0.03) |
The market value of National Research Corp is measured differently than its book value, which is the value of National that is recorded on the company's balance sheet. Investors also form their own opinion of National Research's value that differs from its market value or its book value, called intrinsic value, which is National Research's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because National Research's market value can be influenced by many factors that don't directly affect National Research's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between National Research's value and its price as these two are different measures arrived at by different means. Investors typically determine if National Research is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, National Research's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.